- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02832466
Quantifying the Deterioration of Physical Function in Renal Patients
April 4, 2017 updated by: Eva Segura Ortí, Cardenal Herrera University
Quantifying the Deterioration of Physical Function Along 6 Months in Patients in End Stage Renal Disease
Patients undergoing haemodialysis present a decrease in physical function, but little is known about the rate at which function decreases.
The purpose of this study is quantifying the nature and degree of functional deterioration experienced by stage 5 chronic kidney disease patients during a six month period of maintenance haemodialysis therapy.
Study Overview
Study Type
Observational
Enrollment (Actual)
60
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Valencia
-
Moncada, Valencia, Spain, 46113
- Universidad CEU Cardenal Herrera
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 90 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
People with Chronic Kidney Diseases undergoing hemodialysis treatment
Description
Inclusion Criteria:
- people under hemodialysis treatment at least 3 months
- be medicable stable
- complete all the physical tests
Exclusion Criteria:
- heart stroke in the previous 6 weeks of the study
- inferior limb amputation without artificial aids
- cerebral vascular disease (ictus, ischemic)
- disability to complete functional tests
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from Baseline Short Physical Performance Battery at 6 months
Time Frame: At the beginning of the study and after 6 months
|
Assess lower extremity, which includes objective performance-based measure of balance (side-by-side, semi-tanden and tandem), endurance (4m gait speed) and strength (five chair stands).
Each component was scored from 0 to 4 and when summed yielded Short Physical Performance Battery scores between 0 (poor) and 12 (best).
|
At the beginning of the study and after 6 months
|
Change from Baseline One Leg Standing Test at 6 months
Time Frame: At the beginning of the study and after 6 months
|
Consist in maintain one leg stance for as long as possible.
The test was considered normal if the one leg standing time reached 45 seconds.
|
At the beginning of the study and after 6 months
|
Change from Baseline Timed Up and Go at 6 months
Time Frame: At the beginning of the study and after 6 months
|
To stand up from a standard arms chair, walk 3 meters, turn back the cone walk back and sit down to the chair.
The time in seconds is record.
|
At the beginning of the study and after 6 months
|
Change from Baseline Sit to Stand to Sit 10 and 60 at 6 months
Time Frame: At the beginning of the study and after 6 months
|
For the Sit To Stand 10 participant has to stand up and sit down 10 times and the time needed is record; while for the Sit to stand to sit 60 the participant consist in measures how many repetition the participant can to stand up and sit down during 60 seconds
|
At the beginning of the study and after 6 months
|
Change from Baseline On leg heel rise at 6 months
Time Frame: At the beginning of the study and after 6 months
|
It measures the strength in the triceps surae in the one leg standing position and has to rise the heel.
It measures how many repetitions the participants is can do
|
At the beginning of the study and after 6 months
|
Change from Baseline Handgrip strength at 6 months
Time Frame: At the beginning of the study and after 6 months
|
To measure the amount of strength developed by each hand in kg
|
At the beginning of the study and after 6 months
|
Change from Baseline Six Minutes Walking Time at 6 months
Time Frame: At the beginning of the study and after 6 months
|
To walk the longest distance possible in 6 minutes by walking continuously the 20 or 30 metres indicated on the floor.
It measures the distance in meters
|
At the beginning of the study and after 6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Eva Segura Ortí, Lecturer in the Cardenal Herrera University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2014
Primary Completion (Actual)
December 1, 2016
Study Completion (Actual)
January 1, 2017
Study Registration Dates
First Submitted
July 8, 2016
First Submitted That Met QC Criteria
July 11, 2016
First Posted (Estimate)
July 14, 2016
Study Record Updates
Last Update Posted (Actual)
April 5, 2017
Last Update Submitted That Met QC Criteria
April 4, 2017
Last Verified
April 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Cardenal Herrera Univeristy
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on End Stage Renal Disease
-
Outset MedicalCompletedAcute Kidney Injury | End Stage Renal Disease (ESRD) | End Stage Renal Disease on DialysisUnited States
-
University of Illinois at ChicagoWithdrawnObesity | End-Stage Renal Disease | Renal Disease, End-Stage | Renal Failure, End-StageUnited States
-
Bioconnect Systems, IncCompletedEnd-stage Renal Disease | End-stage Kidney DiseaseUnited States
-
Xinhua Hospital, Shanghai Jiao Tong University...Changhai Hospital; Shanghai Zhongshan Hospital; RenJi Hospital; Ruijin Hospital; Shanghai... and other collaboratorsCompleted
-
Clinical Research Center for End Stage Renal Disease...Kyungpook National University Hospital; Medical Research Collaborating Center... and other collaboratorsActive, not recruitingEnd-Stage Renal DiseaseKorea, Republic of
-
Medtronic - MITGCompletedEnd-stage Renal DiseaseGermany
-
China Medical University HospitalUnknown
-
Guangdong Provincial Hospital of Traditional Chinese...Ministry of Science and Technology of the People´s Republic of ChinaUnknown
-
University of California, San FranciscoCompletedEnd-stage Renal DiseaseUnited States
-
Mark A. LumleyHenry Ford Health SystemCompleted
Clinical Trials on Functional Test
-
Karabuk UniversityNot yet recruiting
-
Pole Sante Grace de DieuRecruiting
-
Gazi UniversityCompletedMultiple SclerosisTurkey
-
National Taiwan University HospitalCompletedRehabilitation | Sports Physical TherapyTaiwan
-
Kırıkkale UniversityCompletedParkinson Disease | Fall | Gait Disorders, Neurologic | Balance; DistortedTurkey
-
Hospital de Clinicas de Porto AlegreAssociação Fundo de Incentivo à PesquisaCompletedPulmonary Disease, Chronic ObstructiveBrazil
-
Caroline LilliecreutzKarolinska Institutet; Lund University; Uppsala University; Göteborg University; Umeå...Recruiting
-
Centre Hospitalier Universitaire de NīmesRecruiting
-
Hospices Civils de LyonCompleted
-
University Hospital, BrestRecruiting